GTO Pharma’s mission is to address an unmet medical need by providing all women with an efficacious, topical, non-hormonal botanically derived pharmaceutical used on an “as needed ” basis for pre- and post-menopausal sexual pain. Additional benefits include increased arousal, lubrication and orgasmic response.

GTO Pharma, in conjunction with its founder, Wendy Epstein, M.D., has developed and owns a robust U.S. and international patent portfolio for topical therapeutics for Female Sexual Disorders (Genitopelvic Pain, Sexual Interest Arousal, and Orgasm). The economic market potential of our patent portfolio is significant given that a substantial number of women suffer from female sexual disorders

GTO Pharma will consider the full range of strategic alternatives including the licensing or sale of its patent portfolio to ensure the availability of effective therapeutics for women’s sexual health and satisfaction.